Soliris eculizumab regulatory update

Alexion said the Japanese Ministry of Health, Labor and Welfare (MHLW) approved an NDA for Soliris eculizumab to treat paroxysmal nocturnal hemoglobinuria (PNH) under the ministry's Priority Review pr...